What they were paid
Anika Therapeutics Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $75,000 | $149,997 | $0 | $0 | $224,997 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Anika Therapeutics, Inc. DEF 14A filed April 28, 2026, accession 0001140361-26-017488, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Anika Therapeutics pays directors a $50,000 cash retainer and $149,997 in RSUs.
Committees
FY2025 · as the proxy prints themAudit · Compensation (Chair)
The rest of the Anika Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Cheryl R. Blanchard, Ph.D | Chair of the Board | $0 |
| Gary P. Fischetti | Independent Director | $212,497 |
| Glenn R. Larsen, Ph.D | Independent Director | $212,497 |
| John B. Henneman, III | Lead Independent Director | $267,497 |
| Joseph H. Capper | Independent Director | $222,497 |
| Stephen D. Griffin | Director | $0 |
| Stephen O. Richard | Independent Director | $229,997 |
| William R. Jellison | Independent Director | $224,997 |
The full Anika Therapeutics compensation record
free company briefThis page is one director within Anika Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat